Immunogen reported $9.21M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Abbvie ABBV:US $ 14342M 383M
Acceleron Pharma XLRN:US $ 34.2M 6.26M
Amgen AMGN:US $ 6706M 180M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Astellas Pharma 4503:JP Y 325523M 620M
AstraZeneca AZN:LN 9866M 1646M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Bristol Myers Squibb BMY:US $ 11624M 79M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Eli Lilly And LLY:US $ 6772.8M 32.7M
Emergent Biosolutions EBS:US $ 329M 68.5M
Exelixis EXEL:US $ 328.42M 56.75M
Halozyme Therapeutics HALO:US $ 115.83M 20.62M
Heron Therapeutics HRTX:US $ 23.23M 0.79M
Immunogen IMGN:US $ 9.21M 7.74M
Intrexon XON:US $ 21.56M 12.02M
Karyopharm Therapeutics KPTI:US $ 37.69M 15.09M
Macrogenics MGNX:US $ 15.66M 15.1M
Nektar Therapeutics NKTR:US $ 24.92M 3.41M
Novartis NVS:US $ 13367M 73M
Pfizer PFE:US $ 24094M 5117M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Seattle Genetics SGEN:US $ 424.06M 35.58M